When it comes to investing, you don't have to sink tens of thousands of dollars into the market.
Even an investment of $1,000 has the potential to grow materially over the long-term.
For example, typically the Australian share market provides investors with an average total return of ~9.5% per annum. That's even after factoring in market shocks like we are experiencing at the moment or the global financial crisis.
Based on this level of return, if you invest $1,000 into the share market every year for 30 years, your investments would grow to be worth $165,000 at the end of the period.
I believe this shows why investing just a relatively small amount each year can still be a very rewarding experience.
With that in mind, here are three shares which I think would be great options for a $1,000 investment in April:
Afterpay Ltd (ASX: APT)
Whilst the coronavirus outbreak is likely to put a dampener on its growth in the near term, I believe this payments company's long-term prospects remain very bright. Especially given the increasing popularity of its buy now pay later platform with consumers and retailers globally. Incidentally, on Monday analysts at Goldman Sachs upgraded its shares to a buy rating with a $25.10 price target. Its analysts believe Afterpay will come out of the current crisis in a stronger position compared to its rivals.
Nanosonics Ltd (ASX: NAN)
Nanosonics is a leading infection control specialist and the company behind the industry-leading trophon EPR disinfection system. This system is used for disinfecting ultrasound probes and has proven incredibly popular with end users. So much so, the system is generating both very strong unit sales and growing recurring revenues from the consumables it requires. The good news is that this best in its class product still has a massive market opportunity and looks well-positioned to capture it. I expect this and the upcoming release of new products to drive strong earnings growth over the next decade.
ResMed Inc. (ASX: RMD)
A final share to consider buying with that $1,000 is ResMed. It is a global medical device company which has a focus on the sleep treatment market. Thanks to its industry-leading products and growing addressable market due to the proliferation of sleep apnoea, I expect it to deliver strong earnings growth over the next decade. The company is also helping out during the coronavirus crisis by manufacturing ventilators.
